Sunlenca Product Label
Interaction Color Code
Clinical Bottom Line
Minimal data to guide interaction: weigh risks and benefits of using this combination
Drug 1
Drug 2
Mechanism
Inhibition of CYP3A4 by lenacapavir
Clinical Effects
Unknown effect on buprenorphine
Management
If initiating buprenorphine in a person already on lenacapavir, start with lowest feasible dose and titrate to clinical effect. If initiating lenacapavir in a person stable on buprenorphine, dose adjustment of buprenorphine may be required. Monitor for clinical efficacy and adverse effects (e.g. sedation, respiratory depression).
Info Source
